Marshall Wace North America’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-27,029
Closed -$876K 1758
2020
Q4
$876K Buy
+27,029
New +$782K ﹤0.01% 971
2019
Q2
Sell
-215,062
Closed -$7.39M 1572
2019
Q1
$7.39M Sell
215,062
-115,322
-35% -$4.23M 0.05% 251
2018
Q4
$10.6M Buy
330,384
+270,111
+448% +$10.2M 0.1% 157
2018
Q3
$2.76M Sell
60,273
-46,524
-44% -$2.34M 0.02% 429
2018
Q2
$5.64M Buy
106,797
+697
+0.7% +$37.1K 0.03% 482
2018
Q1
$5.3M Buy
106,100
+39,771
+60% +$2M 0.03% 555
2017
Q4
$3.18M Buy
+66,329
New +$3.14M 0.02% 703
2017
Q2
Sell
-296,398
Closed -$12.2M 1450
2017
Q1
$12.2M Buy
+296,398
New +$12.4M 0.1% 235
2013
Q4
$167K Sell
6,646
-59,280
-90% -$1.4M ﹤0.01% 650
2013
Q3
$1.52M Buy
65,926
+60,539
+1,124% +$1.38M 0.05% 297
2013
Q2
$110K Buy
+5,387
New +$102K 0.01% 409

Other funds holding SNV

Marshall Wace North America's SNV Position: Q1 2021 in Review

Marshall Wace North America sold out of Synovus (SNV) in Q1 2021, closing a stake of 27,029 shares — an estimated $876K sold.

Marshall Wace North America first reported a position in SNV in Q2 2013 and held it in 11 quarters. The position peaked at $12.2M in Q1 2017. 382 funds tracked by Wall St. Rank hold SNV as of Q1 2021.

  • Marshall Wace North America reported no remaining Synovus position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace North America sold 27,029 Synovus shares in Q1 2021, an estimated $876K.
  • Marshall Wace North America first reported a position in Synovus in Q2 2013 and held it in 11 quarters.
  • Marshall Wace North America's Synovus position peaked at $12.2M in Q1 2017.
  • 382 funds tracked by Wall St. Rank held Synovus as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.